We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Central Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Apr 1, 2024

Central Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Central Asia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Central Asia

For the sixth year in a row, Central Asia recorded growth in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by X% to X kg in 2019. In general, exports, however, showed a precipitous setback. Over the period under review, the exports reached the peak figure at X tons in 2012; however, from 2013 to 2019, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2019. Over the period under review, exports, however, faced a precipitous curtailment. The level of export peaked at $X in 2012; however, from 2013 to 2019, the exports remained at a lower figure.

Exports by Country

The biggest shipments were from Kazakhstan (X kg), together accounting for X% of total export.

Kazakhstan was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2019. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Kazakhstan ($X) also remains the largest prophylactic medicaments containing insulin supplier in Central Asia.

From 2012 to 2019, the average annual rate of growth in terms of value in Kazakhstan totaled X%.

Export Prices by Country

In 2019, the export price in Central Asia amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the export price, however, saw a deep setback. The pace of growth appeared the most rapid in 2014 when the export price increased by X% against the previous year. Over the period under review, the export prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2019, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Kazakhstan.

From 2012 to 2019, the rate of growth in terms of prices for Kazakhstan amounted to X% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Central Asia

In 2022, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the third year in a row after two years of decline. In general, imports recorded a remarkable increase. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. Over the period under review, imports hit record highs in 2022 and are likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Overall, imports recorded a prominent expansion. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. The level of import peaked in 2022 and is likely to see gradual growth in years to come.

Imports by Country

In 2022, Kazakhstan (X tons) was the largest importer of medicaments containing insulin but not antibiotics in measured doses, comprising X% of total imports. Uzbekistan (X tons) held the second position in the ranking, distantly followed by Kyrgyzstan (X tons) and Turkmenistan (X tons). All these countries together took near X% share of total imports. The following importers - Tajikistan (X tons) and Mongolia (X tons) - each accounted for a X% share of total imports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into Kazakhstan stood at X%. At the same time, Turkmenistan (X%), Mongolia (X%), Kyrgyzstan (X%) and Uzbekistan (X%) displayed positive paces of growth. Moreover, Turkmenistan emerged as the fastest-growing importer imported in Central Asia, with a CAGR of X% from 2012-2022. By contrast, Tajikistan (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Uzbekistan, Turkmenistan and Mongolia increased by X, X and X percentage points, respectively.

In value terms, Kazakhstan ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Central Asia, comprising X% of total imports. The second position in the ranking was taken by Uzbekistan ($X), with a X% share of total imports. It was followed by Turkmenistan, with a X% share.

In Kazakhstan, prophylactic medicaments containing insulin imports expanded at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Uzbekistan (X% per year) and Turkmenistan (X% per year).

Import Prices by Country

In 2022, the import price in Central Asia amounted to $X per ton, which is down by X% against the previous year. Over the period under review, the import price showed a perceptible setback. The growth pace was the most rapid in 2020 an increase of X%. The level of import peaked at $X per ton in 2015; however, from 2016 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Kazakhstan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Tajikistan (X%), while the other leaders experienced mixed trends in the import price figures.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting
HANNOVER MESSE 2024

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Kazakhstan remains the largest prophylactic medicaments containing insulin consuming country in Central Asia, comprising approx. 68% of total volume. Moreover, prophylactic medicaments containing insulin consumption in Kazakhstan exceeded the figures recorded by the second-largest consumer, Uzbekistan, fourfold. Kyrgyzstan ranked third in terms of total consumption with a 5% share.
In value terms, Kazakhstan remains the largest prophylactic medicaments containing insulin supplier in Central Asia.
In value terms, Kazakhstan constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Central Asia, comprising 83% of total imports. The second position in the ranking was held by Uzbekistan, with a 10% share of total imports. It was followed by Turkmenistan, with a 2.6% share.
The export price in Central Asia stood at $289,502 per ton in 2019, growing by 1,058% against the previous year.
In 2022, the import price in Central Asia amounted to $205,052 per ton, falling by -13.2% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Central Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Central Asia, split by region and country
  • Trade (exports and imports) in Central Asia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Kazakhstan
    • Kyrgyzstan
    • Mongolia
    • Tajikistan
    • Turkmenistan
    • Uzbekistan

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2024
Eye 364

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.

U.S. - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2024
Eye 340

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..

China - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2024
Eye 321

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.

EU - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2024
Eye 362

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.

World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2024
Eye 435

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Central Asia
Table
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Central Asia - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Central Asia - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Central Asia - Report